Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FBFK7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,369
Award facts
- Contract value 100% obligated
- $29,368.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,368.71 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside restrictions under a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Enbrel, a specialty pharmaceutical product for immunological conditions, represents the type of brand-name therapeutic medication within the company's extensive portfolio that supports military healthcare programs worldwide. The SPE2DX IDC enables flexible ordering of a vast range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. The Defense Logistics Agency's upcoming Pharmaceutical Prime Vendor Global Program Generation V initiative plans to make multiple awards across separate regions, positioning AmerisourceBergen to continue serving as a key vendor for federal military medical procurement.
Quick answers
Who was awarded contract SPE2DB25FBFK7?
SPE2DB25FBFK7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FBFK7 worth?
The government has obligated $29,369 on SPE2DB25FBFK7.
Is contract SPE2DB25FBFK7 an order under another contract?
Yes. SPE2DB25FBFK7 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBFK7 competed?
The extent of competition for SPE2DB25FBFK7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award